Inside Precision Medicine September 24, 2024
Daryl Pritchard, PhD

EDITOR’S NOTE: As a membership-based nonprofit institution dedicated to the advancement of personalized medicine, the Personalized Medicine Coalition (PMC) is working to encourage the clinical adoption of the tools and technologies that make personalized medicine possible. The appended update is designed to inform Inside Precision Medicine’s readers about the Coalition’s progress during the past two years.

As this magazine’s readers may know, on October 31, 2022, PMC and its partners from Diaceutics and Reservoir Communications published a landmark article in JCO Precision Oncology that documented the scope and complexity of clinical practice gaps in personalized medicine.

Twenty years after the completion of the Human Genome Project, this paper provided the first in-depth look at the efforts of United States health...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma / Biotech, Precision Medicine
Advancing Cancer Care: The Role of Radiopharmaceuticals in Precision Medicine
Exploring Precision Medicine and PGx: Sara Rogers, PharmD, Previews Precision Medicine World Conference 2025
India targets to sequence 10 million genomes
23andMe considers sale as cash runs low
23andMe considers a sale as cash runs low

Share This Article